secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zentalis Pharmaceuticals, Inc. (ZNTL)
CIK:        0001725160
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001725160-25-000127
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Zentalis shareholders elect three directors, approve auditor and say-on-pay at annual meeting
--------------------------------------------------------------------------------

- Scott Myers (43.0M for), Karan Takhar (30.7M for), and Luke Walker (36.6M for) elected as Class II directors.
- Ratification of Ernst & Young as auditor approved with 58.1M votes for (over 99.9% of votes cast).
- Advisory say-on-pay passed with 29.5M for vs 17.4M against (~63% of votes cast excluding broker non-votes).
- Total 58.2M shares voted (80.9% of outstanding common stock as of April 21, 2025 record date).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725160/000172516025000127/0001725160-25-000127-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725160/000172516025000127/zntl-20250617.htm
  HTML page:      https://secwatch.observer/filing/0001725160-25-000127

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer